134 related articles for article (PubMed ID: 2968078)
21. [A new ovulation inhibitor antiandrogen].
Millet-part A; Blanes-espi A; Ferrer-barriendos J; Siqueira L; Acosta E
J Bras Ginecol; 1984 Mar; 94(3):91-7. PubMed ID: 12266391
[TBL] [Abstract][Full Text] [Related]
22. [Dermatologic therapy unit anti-androgens].
Nolting S
Fortschr Med; 1977 Mar; 95(12):825-8. PubMed ID: 140141
[TBL] [Abstract][Full Text] [Related]
23. [Significance and adverse effects of oral contraceptives in dermatology].
Schneider HJ
Z Allgemeinmed; 1971 May; 47(15):807-10. PubMed ID: 4253485
[TBL] [Abstract][Full Text] [Related]
24. Experiences in dermatology with various contraceptives containing gestagen.
Vankos J
Gyogyszereink; 1972; 22():59-67. PubMed ID: 12256240
[TBL] [Abstract][Full Text] [Related]
25. Contraception and the dermatologist.
Tyler KH; Zirwas MJ
J Am Acad Dermatol; 2013 Jun; 68(6):1022-9. PubMed ID: 23332517
[TBL] [Abstract][Full Text] [Related]
26. [Acne and chloasma induced by a contraceptive].
Racouchot J; Doline
Bull Soc Fr Dermatol Syphiligr; 1969; 76(1):132. PubMed ID: 4240762
[No Abstract] [Full Text] [Related]
27. [Systematic treatment with sex hormones in dermatology].
Zaun H
Aktuelle Derm; 1976 Feb; 2(1):33-8. PubMed ID: 12308225
[TBL] [Abstract][Full Text] [Related]
28. Dermatologic Conditions in Transgender Populations.
Yeung H; Kahn B; Ly BC; Tangpricha V
Endocrinol Metab Clin North Am; 2019 Jun; 48(2):429-440. PubMed ID: 31027550
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of side effects of current oral contraceptives.
Nelson JH
J Reprod Med; 1971 Feb; 6(2):50-5. PubMed ID: 4255975
[No Abstract] [Full Text] [Related]
30. [Estroprogestational hormones in dermatology].
Chanial G; Villedieu P; Olivier L
Bull Soc Fr Dermatol Syphiligr; 1969; 76(1):125-30. PubMed ID: 4240760
[No Abstract] [Full Text] [Related]
31. Effect of cyclic progestin-estrogen therapy on sebum and acne in women.
Strauss JS; Pochi PE
JAMA; 1964 Nov; 190(9):815-9. PubMed ID: 12254865
[TBL] [Abstract][Full Text] [Related]
32. Adverse cutaneous reaction to oral contraceptives.
Baker H
Br J Dermatol; 1969 Dec; 81(12):946-9. PubMed ID: 4312248
[No Abstract] [Full Text] [Related]
33. Sex hormone binding globulin: the carrier protein for d-norgestrel.
Victor A; Weiner E; Johansson ED
J Clin Endocrinol Metab; 1976 Jul; 43(1):244-7. PubMed ID: 133117
[TBL] [Abstract][Full Text] [Related]
34. [Hair loss during treatment with oral contraceptives].
Lehucher-ceyrac D; Weber-buisset ; Puissant A
Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1265-8. PubMed ID: 12267514
[TBL] [Abstract][Full Text] [Related]
35. The contraceptive implant.
Hohmann H; Creinin MD
Clin Obstet Gynecol; 2007 Dec; 50(4):907-17. PubMed ID: 17982333
[TBL] [Abstract][Full Text] [Related]
36. [Acne and oral contraceptives].
van der Meeren HL; Hamerlynck JV; van der Hurk CM
Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1333-7. PubMed ID: 6237266
[No Abstract] [Full Text] [Related]
37. Restovar--new low-dose, combined, oral contraceptive. Effects on serum proteins, free testosterone and clinical efficacy.
Cullberg G; Adelgaard J; Andersen JN; Andersen ES; Berg H; Bergink EW; Buhl G; Pedersen JH; Poulsen L
Contracept Deliv Syst; 1984 Apr; 5(2):97-104. PubMed ID: 12266201
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of acne.
Harrison PV; Dodman B; Cunliffe WJ
Br Med J; 1979 Aug; 2(6188):495. PubMed ID: 158403
[No Abstract] [Full Text] [Related]
39. [Postcontraceptive acne].
Amann W
ZFA (Stuttgart); 1978 Dec; 54(35-36):1809-12. PubMed ID: 153073
[No Abstract] [Full Text] [Related]
40. Postcontraceptive acne.
Olson RL; Weigand DA
Arch Dermatol; 1972 Jun; 105(6):928. PubMed ID: 4260544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
